Amino acid patterns predict white matter integrity measures in the brain in patients across the Alzheimer’s disease continuum
Authors:
- Farshad GoharmaneshFGFarshad Goharmanesh
- Maryam MasmoieMMMaryam Masmoie
- Hamide NasiriHNHamide Nasiri
- Sayedeh-Fatemeh Sadat-MadaniSSSayedeh-Fatemeh Sadat-Madani
- Sara Montazeri NaminSNSara Montazeri Namin
- Maryam DamizadehMDMaryam Damizadeh
- Shayan ShakeriSSShayan Shakeri
- Fatemeh SodeifianFSFatemeh Sodeifian
- Ali Rajabpour-SanatiARAli Rajabpour-Sanati
- Bahar BahrainianBBBahar Bahrainian
- Yasaman MohammadiYMYasaman Mohammadi
- Ali ShushtariASAli Shushtari
- 18 June 2025
- journal article
- research article
- Published by Springer Nature in Metabolic Brain Disease
- Vol. 40 (6) , 1-15
Abstract
Alzheimer’s disease (AD), the leading cause of dementia, poses a growing global health challenge due to its rising prevalence and socioeconomic impact. Investigating metabolic alterations associated with white matter integrity (WMI) could provide critical insights into AD pathogenesis and identify potential therapeutic targets. This cross-sectional study explored the associations between amino acid (AA) profiles, assessed via ultra-high-performance liquid chromatography (UHPLC), and WMI metrics derived from diffusion tensor imaging (DTI) in individuals across the AD continuum. A total of 176 participants from the Alzheimer’s Disease Neuroimaging Initiative (ADNI) were included and grouped into cognitively normal (CN) individuals (n = 54), patients with mild cognitive impairment (MCI, n = 88), and AD patients (n = 34). WMI was evaluated using DTI-derived metrics, including fractional anisotropy (FA), mean diffusivity (MD), radial diffusivity (RD), and axial diffusivity (AD). AA profiling was conducted using an appropriate panel. Regression analyses, adjusted for age, gender, and education, was used to identify significant associations between AA levels and WMI. Distinct AA alterations were associated with white matter microstructural integrity across study groups. In CN individuals, higher levels of arginine, glycine, and threonine correlated with decreased FA and increased MD, indicating reduced white matter integrity. Conversely, in AD patients, aspartate, glutamate, and histidine exhibited opposite associations, showing positive correlations with FA and negative correlations with MD, suggesting potential neuroprotective or compensatory mechanisms. These findings underscore the associations between AA patterns and white matter integrity and their potential role as AD progression markers. Further investigations into these AA metabolism pathways may identify novel biomarkers for early diagnosis and targets for therapeutic interventions.Keywords
This publication has 41 references indexed in Scilit:
- Blood‐based plasmatic aminoacid profiles as potential biomarkers for dementiaAlzheimer's & Dementia, 2024
- Comparative brain metabolomics reveals shared and distinct metabolic alterations in Alzheimer's disease and progressive supranuclear palsyAlzheimer's & Dementia, 2024
- Optimizing Strategies to Prevent Cognitive Decline With 20-Year Brain ImagingJAMA Network Open, 2024
- Serum metabolic signatures for Alzheimer’s Disease reveal alterations in amino acid composition: a validation studyMetabolomics, 2024
- d-Amino acids: new clinical pathways for brain diseasesTrends in Molecular Medicine, 2023
- Non-invasive biomarkers for mild cognitive impairment and Alzheimer's diseaseNeurobiology of Disease, 2023
- Abnormal white matter changes in Alzheimer's disease based on diffusion tensor imaging: A systematic reviewAgeing Research Reviews, 2023
- NIA‐AA Research Framework: Toward a biological definition of Alzheimer's diseaseAlzheimer's & Dementia, 2018
- Current practice of liquid chromatography–mass spectrometry in metabolomics and metabonomicsJournal of Pharmaceutical and Biomedical Analysis, 2014
- Alzheimer’s disease: amino acid levels and brain metabolic statusNeurological Sciences, 2013